1887
  1. Home
  2. Eurosurveillance
  3. Volume 25, Issue 45, 12/Nov/2020
  4. Article
Editorial Open Access
Like 0
Download
Preview this article:
Preview Magnify

There is no abstract available.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2020.25.45.2001886
2020-11-12
2024-12-22
/content/10.2807/1560-7917.ES.2020.25.45.2001886
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/25/45/eurosurv-25-45-1.html?itemId=/content/10.2807/1560-7917.ES.2020.25.45.2001886&mimeType=html&fmt=ahah

References

  1. European Centre for Disease Prevention and Control (ECDC). COVID-19 situation update for the EU/EEA and the UK, as of 12 Nov 2020. Stockholm: ECDC. [Accessed: 12 Nov 2020]. Available from: https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea
  2. Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56-66.  https://doi.org/10.1016/S1473-3099(18)30605-4  PMID: 30409683 
  3. Bengoechea JA, Bamford CG. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19? EMBO Mol Med. 2020;12(7):e12560.  https://doi.org/10.15252/emmm.202012560  PMID: 32453917 
  4. Cantón R, Gijón D, Ruiz-Garbajosa P. Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic. Curr Opin Crit Care. 2020;26(5):433-41.  https://doi.org/10.1097/MCC.0000000000000755  PMID: 32739970 
  5. Donà D, Di Chiara C, Sharland M. Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact. J Hosp Infect. 2020;106(1):198-9.  https://doi.org/10.1016/j.jhin.2020.05.020  PMID: 32425287 
  6. Getahun H, Smith I, Trivedi K, Paulin S, Balkhy HH. Tackling antimicrobial resistance in the COVID-19 pandemic. Bull World Health Organ. 2020;98(7):442-442A.  https://doi.org/10.2471/BLT.20.268573  PMID: 32742026 
  7. McKenna M. Covid-19 may worsen the antibiotic resistance crisis. Boone: Wired. 23 Apr 2020. Available from: https://www.wired.com/story/covid-19-may-worsen-the-antibiotic-resistance-crisis/
  8. Murray AK. The novel coronavirus COVID-19 outbreak: global implications for antimicrobial resistance. Front Microbiol. 2020;11:1020.  https://doi.org/10.3389/fmicb.2020.01020  PMID: 32574253 
  9. Kampmeier S, Tönnies H, Correa-Martinez CL, Mellmann A, Schwierzeck V. A nosocomial cluster of vancomycin resistant enterococci among COVID-19 patients in an intensive care unit. Antimicrob Resist Infect Control. 2020;9(1):154.  https://doi.org/10.1186/s13756-020-00820-8  PMID: 32962759 
  10. Nori P, Szymczak W, Puius Y, Sharma A, Cowman K, Gialanella P, et al. Emerging co-pathogens: New Delhi Metallo-beta-lactamase producing Enterobacterales infections in New York City COVID-19 patients. Int J Antimicrob Agents. 2020;106179:106179.  https://doi.org/10.1016/j.ijantimicag.2020.106179  PMID: 32987104 
  11. Porretta AD, Baggiani A, Arzilli G, Casigliani V, Mariotti T, Mariottini F, et al. Increased risk of acquisition of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE) among a cohort of COVID-19 patients in a teaching hospital in Tuscany, Italy. Pathogens. 2020;9(8):635.  https://doi.org/10.3390/pathogens9080635  PMID: 32764228 
  12. Tiri B, Sensi E, Marsiliani V, Cantarini M, Priante G, Vernelli C, et al. Antimicrobial stewardship program, COVID-19, and infection control: Spread of carbapenem-resistant Klebsiella pneumoniae colonization in ICU COVID-19 patients. What did not work? J Clin Med. 2020;9(9):E2744.  https://doi.org/10.3390/jcm9092744  PMID: 32854334 
  13. Chowdhary A, Tarai B, Singh A, Sharma A. Multidrug-resistant Candida auris infections in critically ill coronavirus disease patients, India, April-July 2020. Emerg Infect Dis. 2020;26(11):2694-6.  https://doi.org/10.3201/eid2611.203504  PMID: 32852265 
  14. Posteraro B, Torelli R, Vella A, Leone PM, De Angelis G, De Carolis E, et al. Pan-echinocandin-resistant Candida glabrata bloodstream infection complicating COVID-19: a fatal case report. J Fungi (Basel). 2020;6(3):163.  https://doi.org/10.3390/jof6030163  PMID: 32899996 
  15. Meijer EFJ, Dofferhoff ASM, Hoiting O, Buil JB, Meis JF. Azole-resistant COVID-19-associated pulmonary aspergillosis in an immunocompetent host: a case report. J Fungi (Basel). 2020;6(2):79.  https://doi.org/10.3390/jof6020079  PMID: 32517166 
  16. Contou D, Claudinon A, Pajot O, Micaëlo M, Longuet Flandre P, Dubert M, et al. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care. 2020;10(1):119.  https://doi.org/10.1186/s13613-020-00736-x  PMID: 32894364 
  17. Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al. Incidence of co-infections and superinfections in hospitalised patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2020;S1198-743X(20)30450-X.  https://doi.org/10.1016/j.cmi.2020.07.041 
  18. Bentivegna E, Alessio G, Spuntarelli V, Luciani M, Santino I, Simmaco M, et al. Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection. Am J Infect Control. 2020 Oct 5;S0196-6553(20)30891-9.  https://doi.org/10.1016/j.ajic.2020.09.010 
  19. Fattorini L, Creti R, Palma C, Pantosti A, Unit of Antibiotic Resistance and Special Pathogens, Unit of Antibiotic Resistance and Special Pathogens of the Department of Infectious Diseases, Istituto Superiore di Sanità, Rome. Bacterial coinfections in COVID-19: an underestimated adversary. Ann Ist Super Sanita. 2020;56(3):359-64.  https://doi.org/10.4415/ANN_20_03_14  PMID: 32959802 
  20. European Centre for Disease Prevention and Control (ECDC). Surveillance Atlas of Infectious Diseases. Stockholm: ECDC. [Accessed: 23 Oct 2020]. Available from: https://atlas.ecdc.europa.eu/public/index.aspx
  21. Nieuwlaat R, Mbuagbaw L, Mertz D, Burrows L, Bowdish DME, Moja L, et al. Coronavirus Disease 2019 and antimicrobial resistance: parallel and interacting health emergencies. Clin Infect Dis. 2020:ciaa773.  https://doi.org/10.1093/cid/ciaa773 
  22. European Centre for Disease Prevention and Control (ECDC). Antimicrobial consumption database (ESAC-Net). Stockholm: ECDC. [Accessed: 23 Oct 2020]. Available from: https://www.ecdc.europa.eu/en/antimicrobial-consumption/surveillance-and-disease-data/database
  23. World Health Organization Regional Office for Europe (WHO/Europe). Antimicrobial resistance – Publications. Copenhagen: WHO/Europe. [Accessed: 27 Oct 2020]. Available from: https://www.euro.who.int/en/health-topics/disease-prevention/antimicrobial-resistance/publications
  24. European Medicines Agency (EMA). European Surveillance of Veterinary Antimicrobial Consumption, 2020: sales of veterinary antimicrobial agents in 31 European countries in 2018 (EMA/24309/2020). Amsterdam: EMA; 2020. Available from: https://www.ema.europa.eu/en/documents/report/sales-veterinary-antimicrobial-agents-31-european-countries-2018-trends-2010-2018-tenth-esvac-report_en.pdf
  25. World Health Organization (WHO). Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2020. Geneva: WHO; 26 May 2020. Available from: https://www.who.int/glass/resources/publications/early-implementation-report-2020/en/
  26. Leitmeyer KC, Espinosa L, Broberg EK, Struelens MJ, ECDC National Focal Points laboratory e-reporting survey group members, ECDC National Focal Points laboratory e-reporting survey group. Automated digital reporting of clinical laboratory information to national public health surveillance systems, results of a EU/EEA survey, 2018. Euro Surveill. 2020;25(39):1900591.  https://doi.org/10.2807/1560-7917.ES.2020.25.39.1900591  PMID: 33006301 
  27. Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). Providing a Roadmap for Automated Infection Surveillance in Europe (PRAISE). Stockholm: JPIAMR. [Accessed: 27 Oct 2020]. Available from: https://www.jpiamr.eu/wp-content/uploads/2018/11/Summary_PRAISE.pdf
  28. López-Lozano JM, Lawes T, Nebot C, Beyaert A, Bertrand X, Hocquet D, et al. , THRESHOLDS study group. A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance. Nat Microbiol. 2019;4(7):1160-72.  https://doi.org/10.1038/s41564-019-0410-0  PMID: 30962570 
  29. Armstrong J, Rudkin JK, Allen N, Crook DW, Wilson DJ, Wyllie DH, et al. Dynamic linkage of COVID-19 test results between Public Health England’s Second Generation Surveillance System and UK Biobank. Microb Genom. 2020;6(7):mgen000397.  https://doi.org/10.1099/mgen.0.000397  PMID: 32553051 
  30. Opalska A, Kwa M, Hubert Leufkens H, Gardarsdottir H. Enabling appropriate use of antibiotics: review of European Union procedures of harmonising product information, 2007 to 2020. Euro Surveill. 2020;25(45):2000035.  https://doi.org/10.2807/1560-7917.ES.2020.25.45.2000035 
  31. Peñalva G, Högberg LD, Weist K, Vlahović-Palčevski V, Heuer O, Monnet DL, ESAC-Net Study Group, EARS-Net Study Group. Decreasing and stabilising trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae in segmented regression analysis, European Union/European Economic Area, 2001 to 2018. Euro Surveill. 2019;24(46):1900656.  https://doi.org/10.2807/1560-7917.ES.2019.24.46.1900656  PMID: 31771708 
  32. Lötsch F, Albiger B, Monnet DL, Struelens M, Seifert H, Kohlenberg A, European Antimicrobial Resistance Genes Surveillance Network. (EURGen-Net) carbapenem-resistant Acinetobacter baumannii capacity survey group. Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019. Euro Surveill. 2020;25(45):2001735.
  33. Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;S1198-743X(20)30423-7.
  34. Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;ciaa530.  https://doi.org/10.1093/cid/ciaa530 
  35. Beović B, Doušak M, Ferreira-Coimbra J, Nadrah K, Rubulotta F, Belliato M, et al. Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey. J Antimicrob Chemother. 2020;dkaa326.  https://doi.org/10.1093/jac/dkaa326 
  36. Abelenda-Alonso G, Padullés A, Rombauts A, Gudiol C, Pujol M, Alvarez-Pouso C, et al. Antibiotic prescription during the COVID-19 pandemic: A biphasic pattern. Infect Control Hosp Epidemiol. 2020;41(11):1371-2.  https://doi.org/10.1017/ice.2020.381  PMID: 32729437 
  37. Mazdeyasna H, Nori P, Patel P, Doll M, Godbout E, Lee K, et al. Antimicrobial stewardship at the core of COVID-19 response efforts: implications for sustaining and building programs. Curr Infect Dis Rep. 2020;22(9):23.  https://doi.org/10.1007/s11908-020-00734-x  PMID: 32834785 
  38. Furukawa D, Graber CJ. Antimicrobial stewardship in a pandemic: picking up the pieces. Clin Infect Dis. 2020;ciaa1273. PMID: 32857832 
  39. European Association of Hospital Pharmacists (EAHP). 2018 EAHP Medicines shortages report. Medicines shortages in European hospitals. Brussels: EAHP; 2018. Available from: https://www.eahp.eu/sites/default/files/shortages_report05online.pdf
  40. ReAct – Action on Antibiotic Resistance. Shortages and AMR – why should we care? Four consequences of antibiotic shortages. ReAct; 12 Mar 2020. Available from: https://www.reactgroup.org/news-and-views/news-and-opinions/year-2020/shortages-and-amr-why-should-we-care-4-consequences-of-antibiotic-shortages/
  41. Chang CY, Chan KG. Underestimation of co-infections in COVID-19 due to non-discriminatory use of antibiotics. J Infect. 2020;81(3):e29-30.  https://doi.org/10.1016/j.jinf.2020.06.077  PMID: 32628960 
  42. O’Reilly-Shah VN, Van Cleve W, Long DR, Moll V, Evans FM, Sunshine JE, et al. Impact of COVID-19 response on global surgical volumes: an ongoing observational study. Bull World Health Organ. 2020;98(10):671-82.  https://doi.org/10.2471/BLT.20.264044 
  43. Mulholland RH, Wood R, Stagg HR, Fischbacher C, Villacampa J, Simpson CR, et al. Impact of COVID-19 on accident and emergency attendances and emergency and planned hospital admissions in Scotland: an interrupted time-series analysis. J R Soc Med. 2020;113(11):444-53.  https://doi.org/10.1177/0141076820962447  PMID: 33012218 
  44. Sokolski M, Gajewski P, Zymlinski R, Biegus J, Berg JMT, Bor W, et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on acute admissions at the emergency and cardiology departments across Europe. Am J Med. 2020;S0002-9343(20)30825-1.  https://doi.org/10.1016/j.amjmed.2020.08.043 
  45. Ford S. Infection control concerns spark new advice on PPE use during Covid-19 crisis. Braintree. Nurs Times. 2020;21. Available from: https://www.nursingtimes.net/news/policies-and-guidance/infection-control-concerns-spark-new-advice-on-ppe-use-during-covid-19-crisis-21-05-2020/
  46. Meda M, Gentry V, Reidy P, Garner D. Unintended consequences of long-sleeved gowns in a critical care setting during the COVID-19 pandemic. J Hosp Infect. 2020;S0195-6701(20)30367-4.  https://doi.org/10.1016/j.jhin.2020.07.036 
  47. Stevens MP, Doll M, Pryor R, Godbout E, Cooper K, Bearman G. Impact of COVID-19 on traditional healthcare-associated infection prevention efforts. Infect Control Hosp Epidemiol. 2020;41(8):946-7.  https://doi.org/10.1017/ice.2020.141  PMID: 32297849 
  48. Nasir M, Salauddin Chowdhury ASM, Zahan T. Self-medication during COVID-19 outbreak: a cross sectional online survey in Dhaka city. Int J Basic Clin Pharmacol. 2020;9(9):1325-30.  https://doi.org/10.18203/2319-2003.ijbcp20203522 
  49. Morgan W. Coronavirus: heavy use of hand sanitisers could boost antimicrobial resistance. London: The Conversation; 17 Apr 2020. Available from: https://theconversation.com/coronavirus-heavy-use-of-hand-sanitisers-could-boost-antimicrobial-resistance-136541
  50. Kommenda N. How is the coronavirus affecting global air traffic? London: The Guardian; 3 Apr 2020. Available from: https://www.theguardian.com/world/ng-interactive/2020/apr/03/how-is-the-coronavirus-affecting-global-air-traffic
  51. Comber SDW, Upton M, Lewin S, Powell N, Hutchinson TH. COVID-19, antibiotics and One Health: a UK environmental risk assessment. J Antimicrob Chemother. 2020;dkaa338.  https://doi.org/10.1093/jac/dkaa338 
  52. Jeffery A, Newburger E. Wasted milk, euthanized livestock: Photos show how coronavirus has devastated US agriculture. New York: CNBC; 2 May 2020. Available from: https://www.cnbc.com/2020/05/02/coronavirus-devastates-agriculture-dumped-milk-euthanized-livestock.html
Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Dominique+L+Monnet&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Monnet Dominique L</a>, <a href="/search?value1=Stephan+Harbarth&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Harbarth Stephan</a></span>. Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?. <a href="/content/ecdc">Euro Surveill.</a> 2020;25(45):pii=2001886. <a href="https://doi.org/10.2807/1560-7917.ES.2020.25.45.2001886" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2020.25.45.2001886</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 04 Nov 2020;&nbsp;&nbsp; <span class="generated">Accepted</span>: 12 Nov 2020 </span> </p>
/content/10.2807/1560-7917.ES.2020.25.45.2001886
/content/10.2807/1560-7917.ES.2020.25.45.2001886
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error